The long-term goal of the proposed research is to develop multi-modality, image-based markers for? assessing breast density and parenchyma! structure that may be used alone or together with clinical? measures, as well as biomarkers, for use in determining risk of breast cancer. The general hypothesis is? that inclusion of automated analyses of the parenchyma will improve the assessment of breast cancer risk.? The specific objectives of the proposed research are (1) to perform mage-based categorization of patient? databases based on breast density, parenchyma morphology, and parenchyma kinetics [that will be? automatically extracted], (2) perform correlation and modeling of the various descriptors of breast density? and parenchymal characteristics (i.e. image-markers) with known surrogate markers of risk (such as? BRCA1 and BRCA2 heterozygotes and presence of cancer on the contralateral breast) to yield new imagebased? markers of risk, (3) perform correlation of the various descriptors of breast density and parenchymal? characteristics (i.e. image-markers) with developing biomarkers and candidate genes to yield better? understanding of breast cancer risk, and (4) perform preclinical assessment and translation of the density? and parenchymal characteristics of women at high risk using these new models. This clinical translational? component will involve quantitative comparison with the current method of risk assessment of the Gail? model and a case control study with databases from other institutions relating the image-based markers to? onset of cancer. In the future, it is expected that such image-based markers will be useful for improved? assessment of patients at high risk for breast cancer and for monitoring the response of preventive? treatments. The proposed research is novel in that other correlative research in breast cancer risk with? image-based analyses involves only breast density. However, here we incorporate two additional,? potentially complementary, analyses of the breast parenchyma into the correlative and modeling research.? The University of Chicago is extremely well-positioned to perform this correlative research on multimodality? image-based analyses for breast cancer risk because of its 20-year history of developing multimodality? computer-aided diagnosis methods for mammography, sonography, and MRI, and its integration? with the University of Chicago Cancer Risk Clinic.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA125183-03
Application #
7668451
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
3
Fiscal Year
2008
Total Cost
$357,244
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Guindalini, Rodrigo Santa; Zheng, Yonglan; Abe, Hiroyuki et al. (2018) Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clin Cancer Res :
Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620
Zheng, Yonglan; Walsh, Tom; Gulsuner, Suleyman et al. (2018) Inherited Breast Cancer in Nigerian Women. J Clin Oncol 36:2820-2825
Wang, Shengfeng; Ogundiran, Temidayo; Ademola, Adeyinka et al. (2018) Development of a Breast Cancer Risk Prediction Model for Women in Nigeria. Cancer Epidemiol Biomarkers Prev 27:636-643
Debiasi, Márcio; Polanczyk, Carisi A; Ziegelmann, Patrícia et al. (2018) Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Front Oncol 8:156
Michailidou, Kyriaki (see original citation for additional authors) (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551:92-94
Rudin, Shoshana; Marable, Marcus; Huang, R Stephanie (2017) The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment. Genomics Proteomics Bioinformatics 15:82-93
Geeleher, Paul; Huang, R Stephanie (2017) Exploring the Link between the Germline and Somatic Genome in Cancer. Cancer Discov 7:354-355
Hon, Jason; Hwang, Michelle S; Charnetzki, Meara A et al. (2017) Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates. J Biol Inorg Chem 22:1267-1279
Milne, Roger L (see original citation for additional authors) (2017) Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet 49:1767-1778

Showing the most recent 10 out of 203 publications